|1.||Ohe, Tatsuhiko: 1 article (10/2004)|
|2.||Inamori, Yoshihiko: 1 article (10/2004)|
|3.||Okabe, Toshihiro: 1 article (10/2004)|
|4.||Morita, Yasuhiro: 1 article (10/2004)|
|5.||Ishida, Nakao: 1 article (10/2004)|
|6.||Matsumura, Eiko: 1 article (10/2004)|
|7.||Fukui, Toru: 1 article (10/2004)|
|8.||Tsujibo, H: 1 article (03/2001)|
|9.||Morita, Y: 1 article (03/2001)|
|10.||Yasuda, M: 1 article (03/2001)|
|1.||Stomach Neoplasms (Stomach Cancer)
10/01/2004 - "At the same time after treatment, the growth of the murine P388 lymphocytic leukemia cell line was completely suppressed by the three compounds at concentrations higher than 5.0 microg/ml. Among these three compounds, gamma-thujaplicin had the strongest cytotoxic activity on the growth of this tumor cell line in vitro."
10/01/2004 - "At 48 h after treatment, gamma-thujaplicin and 4-acetyltropolone at 0.63 microg/ml inhibited cell growth of murine P388 lymphocytic leukemia by 85% and 65%, respectively. "
10/01/2004 - "In particular, beta-dolabrin and 4-acetyltropolone showed strong antifungal activity against Pythium aphanidermatum IFO 32440, with minimum inhibitory concentration (MIC) values of 6.0 microg/ml. Secondly, beta-dolabrin, gamma-thujaplicin and 4-acetyltropolone had obvious growth-inhibitory effect on two kinds of Legionella sp. 4-Acetyltropolone especially had strong antibacterial activity toward Legionella pneumophila SG 1, and its MIC value was 3.1 microg/ml. These three compounds showed cytotoxic effects against murine P388 lymphocytic leukemia cell line in vitro. "